⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 11, 2020

Visudyne 15 mg Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung)

📷 Wikipedia: Verteporfin · Source
Visudyne 15 mg Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung)
📷 Wikipedia: Verteporfin · Source
Parallel export ban in effect. Supply limited due to manufacturing capacity issues. Affected packs: one vial, restricted since July 31, 2020, with resupply expected December 31, 2026.
🗄
Archived (older alert)
This alert was reported 2286 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
119 days in total
May 18, 2026 September 14, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Visudyne is a medicine given by a doctor as a drip. It helps treat eye problems.

What's happening? There is not enough Visudyne because making it is hard right now. Supplies will be low until the end of 2026.

Does this affect me? If you need Visudyne in Austria, you may have trouble getting it.

What should I do? Ask your pharmacist or doctor for help. They can suggest other options.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
VERTEPORFIN
Agency-published detail

🚫 Parallel export ban active · ATC: S01LA01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Federal Republic of Germany · Affected packs: 1 Stück Durchstechflasche [eingeschränkt verfügbar, since 2020-07-31, resupply 2026-12-31]

First published
June 11, 2020
Last refreshed by us
3 months ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Visudyne 15 mg Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung). Parallel export ban in effect. Supply limited due to manufacturing capacity issues. Affected packs: one vial, restricted since July 31, 2020, with resupply expected December 31, 2026.
▸ When was this alert issued?
This alert was issued on June 11, 2020 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.